JP2025514636A5 - - Google Patents

Info

Publication number
JP2025514636A5
JP2025514636A5 JP2024558241A JP2024558241A JP2025514636A5 JP 2025514636 A5 JP2025514636 A5 JP 2025514636A5 JP 2024558241 A JP2024558241 A JP 2024558241A JP 2024558241 A JP2024558241 A JP 2024558241A JP 2025514636 A5 JP2025514636 A5 JP 2025514636A5
Authority
JP
Japan
Prior art keywords
antibody
seq
antigen
binding fragment
sequence shown
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024558241A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025514636A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/085460 external-priority patent/WO2023186092A1/zh
Publication of JP2025514636A publication Critical patent/JP2025514636A/ja
Publication of JP2025514636A5 publication Critical patent/JP2025514636A5/ja
Pending legal-status Critical Current

Links

JP2024558241A 2022-04-02 2023-03-31 ｃ－Ｍｅｔに対するモノクローナル抗体及び二重特異性抗体 Pending JP2025514636A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN202210343364.4 2022-04-02
CN202210345737 2022-04-02
CN202210345737.1 2022-04-02
CN202210343364 2022-04-02
PCT/CN2023/085460 WO2023186092A1 (zh) 2022-04-02 2023-03-31 针对c-Met的单克隆抗体以及双特异性抗体

Publications (2)

Publication Number Publication Date
JP2025514636A JP2025514636A (ja) 2025-05-09
JP2025514636A5 true JP2025514636A5 (enExample) 2025-08-07

Family

ID=88199447

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024558241A Pending JP2025514636A (ja) 2022-04-02 2023-03-31 ｃ－Ｍｅｔに対するモノクローナル抗体及び二重特異性抗体

Country Status (11)

Country Link
US (1) US20250223366A1 (enExample)
EP (1) EP4506363A4 (enExample)
JP (1) JP2025514636A (enExample)
KR (1) KR20240168447A (enExample)
CN (1) CN119013296A (enExample)
AU (1) AU2023247654A1 (enExample)
CL (1) CL2024002974A1 (enExample)
IL (1) IL315910A (enExample)
MX (1) MX2024012143A (enExample)
WO (1) WO2023186092A1 (enExample)
ZA (1) ZA202408262B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025146619A1 (ko) * 2024-01-02 2025-07-10 주식회사 종근당 항 c-met 항체를 포함하는 항암 조합물
WO2025185602A1 (en) * 2024-03-05 2025-09-12 Hansoh Bio Llc Immunoconjugates and pharmaceutical uses thereof
WO2025190404A1 (zh) * 2024-03-14 2025-09-18 珠海普米斯生物科技有限公司 双特异性抗体、抗体药物偶联物及其应用
WO2025247330A1 (zh) * 2024-05-31 2025-12-04 江苏先声生物制药有限公司 抗EGFR×cMet双特异性抗体的药物偶联物及其用途
CN121868507A (zh) * 2024-10-16 2026-04-17 上海安领科生物医药有限公司 抗EGFR和cMET双特异性抗体的抗体药物偶联物
WO2026145588A1 (en) * 2024-12-31 2026-07-09 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Use of egfr/c-met bispecific binding protein
CN121045385B (zh) * 2025-11-03 2026-02-10 广州安必平医药科技股份有限公司 一种抗c-met蛋白单克隆抗体及其相关产品和用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
KR100945108B1 (ko) 2001-06-13 2010-03-02 젠맵 에이/에스 표피 성장 인자 수용체 (ｅｇｆｒ)에 대한 인간모노클로날 항체
HN2004000285A (es) * 2003-08-04 2006-04-27 Pfizer Prod Inc ANTICUERPOS DIRIGIDOS A c-MET
ME01803B (me) * 2004-08-05 2010-12-31 Genentech Inc Humanizovani anti-cmet antagonisti
BRPI0709917A2 (pt) * 2006-03-30 2011-07-05 Novartis Ag composições e métodos de uso para anticorpos de c-met
SG188802A1 (en) * 2008-03-06 2013-04-30 Genentech Inc Combination therapy with c-met and egfr antagonists
EP3904391B1 (en) 2010-03-10 2024-07-10 Genmab A/S Monoclonal antibodies against c-met
KR20130037153A (ko) * 2011-10-05 2013-04-15 삼성전자주식회사 항 ｃ-Ｍｅｔ 항체 및 그의 용도
KR101844479B1 (ko) * 2011-11-17 2018-04-03 삼성전자주식회사 항 ｃ-Ｍｅｔ 항체 및 그의 용도
US20170275367A1 (en) * 2012-11-21 2017-09-28 Janssen Biotech, Inc. Bispecific EGFR/C-Met Antibodies
TW201609805A (zh) * 2013-12-23 2016-03-16 美國禮來大藥廠 結合ｅｇｆｒ及ｍｅｔ之多功能抗體
EP3630844A4 (en) * 2017-05-30 2021-03-03 Chong Kun Dang Pharmaceutical Corp. NOVEL ANTI-C-MET ANTIBODY AND USE OF IT
AU2020357944A1 (en) 2019-09-30 2022-03-31 Adimab, Llc CH1 domain variants engineered for preferential light chain pairing and multispecific antibodies comprising the same

Similar Documents

Publication Publication Date Title
JP7502549B2 (ja) 抗体－薬物コンジュゲートの薬物部位を認識する蛋白質
CN115551889A (zh) 抗cd73抗体及其用途
JP2022535553A5 (enExample)
KR102580319B1 (ko) 항 ceacam6 항체 및 사용 방법
EP3180356B1 (en) Human anti-fgfr4 antibody
JP7094893B2 (ja) エンドシアリン結合抗体
JP2023527937A5 (enExample)
JP2025525408A (ja) 二重特異性抗体及びその応用
JP2025512119A5 (enExample)
CN111278992A (zh) 用抗egfr抗体治疗癌症的组合物和方法
JP2024532836A5 (enExample)
JP2022502079A5 (enExample)
JP2025513930A5 (enExample)
JP2024533993A5 (enExample)
RU2707121C9 (ru) АНТИТЕЛО, СПЕЦИФИЧЕСКИ СВЯЗЫВАЮЩЕЕСЯ С ErbB3, И ЕГО ПРИМЕНЕНИЕ
JP2025513767A5 (enExample)
CN114616245B (zh) 一种抗cd38的抗体及其用途
JP2024508597A5 (enExample)
JP2024502670A5 (enExample)
WO2016163433A1 (ja) 抗ｆｇｆｒ２抗体と他剤を含む組成物
EP4506361A1 (en) Antibody against c-met and use thereof
WO2025239422A1 (ja) コートマータンパク質複合体サブユニットベータ２に対する抗体
HK40083261A (en) Anti-cd73 antibody and use thereof
NZ783695B2 (en) Binding molecule specific for cd73 and use of binding molecule
RU2022107092A (ru) Новые анти-cldn18.2 антитела